{"id":2166,"date":"2010-01-27T00:00:00","date_gmt":"2010-01-27T00:00:00","guid":{"rendered":"http:\/\/fefac.cat\/empresarial\/?p=2166"},"modified":"2020-10-06T16:27:56","modified_gmt":"2020-10-06T14:27:56","slug":"un-estudi-de-lagncia-espanyola-de-medicaments-re","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/","title":{"rendered":"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital"},"content":{"rendered":"<p>Quatre mesos despr\u00e9s d\u2019aprovar la lliure dispensaci\u00f3 de la p\u00edndola postcoital (PDD), un informe d\u2019avaluaci\u00f3 de medicaments amb levonorgestrel autoritzats elaborat per l\u2019Ag\u00e8ncia Espanyola de Medicaments (AEMPS) que contradiu el que ve dient el Ministeri de Sanitat referent als efectes d\u2019aquest medicament.<\/p>\n<p>El document de l\u2019AEMPS recull un risc potencial que, fins ara, no se li havia atribu\u00eft per falta d\u2019efici\u00e8ncia cient\u00edfica i que \u00e9s el tromboembolisme ven\u00f3s. L\u2019informe afirma que no es pot descartar aquest efecte en dones que facin un \u00fas repetit i freq\u00fcent de la PDD.<\/p>\n<p>Part de la comunitat cient\u00edfica i farmac\u00e8utica considera que aquest risc no es pot descartar i que ho hauria de recollir la fitxa t\u00e8cnica del f\u00e0rmac mentre que altres opinen que no hi ha evid\u00e8ncies suficients per afirmar que existeix aquest efecte i que ni la pr\u00f2pia AEMPS hi aporta dades.<\/p>\n<p>De moment, el PP ha presentat una proposici\u00f3 no de llei per tal de donar marxa enrere a la lliure dispensaci\u00f3 de la p\u00edndola.<\/p>\n<p><strong>FONT: EL GLOBAL<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Quatre mesos despr\u00e9s d\u2019aprovar la lliure dispensaci\u00f3 de la p\u00edndola postcoital (PDD), un informe d\u2019avaluaci\u00f3 de medicaments amb levonorgestrel autoritzats elaborat per l\u2019Ag\u00e8ncia Espanyola de Medicaments (AEMPS) que contradiu el [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[10,11,12,13,14,15,101],"tags":[70],"class_list":["post-2166","post","type-post","status-publish","format-standard","hentry","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-sanitaria","tag-pindola-postcoital"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital - FEFAC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital - FEFAC\" \/>\n<meta property=\"og:description\" content=\"Quatre mesos despr\u00e9s d\u2019aprovar la lliure dispensaci\u00f3 de la p\u00edndola postcoital (PDD), un informe d\u2019avaluaci\u00f3 de medicaments amb levonorgestrel autoritzats elaborat per l\u2019Ag\u00e8ncia Espanyola de Medicaments (AEMPS) que contradiu el [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2010-01-27T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-06T14:27:56+00:00\" \/>\n<meta name=\"author\" content=\"qabh859\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"qabh859\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/\"},\"author\":{\"name\":\"qabh859\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"headline\":\"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital\",\"datePublished\":\"2010-01-27T00:00:00+00:00\",\"dateModified\":\"2020-10-06T14:27:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/\"},\"wordCount\":206,\"keywords\":[\"p\u00edndola postcoital\"],\"articleSection\":[\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/\",\"name\":\"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"datePublished\":\"2010-01-27T00:00:00+00:00\",\"dateModified\":\"2020-10-06T14:27:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/un-estudi-de-lagncia-espanyola-de-medicaments-re\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\",\"name\":\"qabh859\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/qabh859\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital - FEFAC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/","og_locale":"ca_ES","og_type":"article","og_title":"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital - FEFAC","og_description":"Quatre mesos despr\u00e9s d\u2019aprovar la lliure dispensaci\u00f3 de la p\u00edndola postcoital (PDD), un informe d\u2019avaluaci\u00f3 de medicaments amb levonorgestrel autoritzats elaborat per l\u2019Ag\u00e8ncia Espanyola de Medicaments (AEMPS) que contradiu el [&hellip;]","og_url":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/","og_site_name":"FEFAC","article_published_time":"2010-01-27T00:00:00+00:00","article_modified_time":"2020-10-06T14:27:56+00:00","author":"qabh859","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"qabh859","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/"},"author":{"name":"qabh859","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"headline":"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital","datePublished":"2010-01-27T00:00:00+00:00","dateModified":"2020-10-06T14:27:56+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/"},"wordCount":206,"keywords":["p\u00edndola postcoital"],"articleSection":["Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","Sanit\u00e0ria"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/","url":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/","name":"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"datePublished":"2010-01-27T00:00:00+00:00","dateModified":"2020-10-06T14:27:56+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/un-estudi-de-lagncia-espanyola-de-medicaments-re\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Un estudi de l\u2019Ag\u00e8ncia Espanyola de Medicaments revela efectes indesitjats de la p\u00edndola postcoital"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7","name":"qabh859","url":"https:\/\/fefac.cat\/empresarial\/author\/qabh859\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/2166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=2166"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/2166\/revisions"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=2166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=2166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=2166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}